Company / Current Liabilities
OptimizeRx Corp Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$21.3M
FY2025
5-year range
$8.4M / $21.3M
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 3 consecutive years, from $8M in FY2022 to $21M in FY2025.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +16.2%.
Increased from $18M to $21M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +36.3%
- 5-Year CAGR
- +16.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +16.2%, indicating consistent growth.
- In FY2025, current liabilities increased 14.0% year-over-year.
- Lowest current liabilities in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.3M | +14.0% |
| FY2024 | $18.7M | +4.3% |
| FY2023 | $17.9M | +113.0% |
| FY2022 | $8.4M | -16.3% |
| FY2021 | $10.0M | +0.0% |
| FY2020 | $10.0M | +64.2% |
| FY2019 | $6.1M | +44.3% |
| FY2018 | $4.2M | +19.4% |
| FY2017 | $3.5M | -3.4% |
| FY2016 | $3.7M | +8.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026